Fisher & Paykel Healthcare Corporation Limited has been made aware of unauthorised and unlawful access to two employee email accounts and a subset of company files. The company immediately activated its response protocols to contain the incident and investigate the nature and extent of the activity.
There has been no impact to the company’s products, manufacturing operations or supply chain, and its ability to supply and support customers and patients continues uninterrupted. There is no evidence that the unlawful activity compromised the company’s system that maintains patient data.
Some of the files accessed contained personally identifiable information and the company is in the process of notifying those affected. The company has also notified relevant authorities.
The company has identified no evidence of ransomware or malware, believes the incident has been contained and does not expect any material impact on its financials or operations.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Contact
|
|
|
|
Investors:
Dan Adolph
Head of Investor Relations
[email protected]
+64 (0) 22 511 4050
|
|
|
Authorised by Fisher & Paykel Healthcare Corporation Limited’s Chief Executive Officer.